Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
May
18
2023
FDA Releases Draft Compliance Policy Guide on Major Food Allergen Labeling and Cross-Contact Keller and Heckman LLP
May
18
2023
California Assembly Passes Ban on Chemicals in Processed Food Keller and Heckman LLP
May
18
2023
Third Party Administrator and Pharmacy Benefit Manager Licensing and Compliance Developments Polsinelli PC
May
18
2023
U.S. Executive Branch Update – May 18, 2023 Squire Patton Boggs (US) LLP
May
18
2023
Weeded Out: Drug Paraphernalia Mark Described as “Essential Oil Dispenser” Refused Registration McDermott Will & Emery
May
18
2023
FDA and SAMHSA Issue Joint Statement in Support of Reducing Barriers to Evidence Based Treatments Foley & Lardner LLP
May
17
2023
Defense Victory in Mislabeling Lawsuit Affirmed on Preemption Grounds Keller and Heckman LLP
May
17
2023
Supreme Court Narrows Dormant Commerce Clause Protections Against Regulation of Business in Decision Affirming California Pork Law Beveridge & Diamond PC
May
17
2023
PERSON VERSUS ENTITY: Where you fall in the definition matters with CIPA Troutman Amin, LLP
May
16
2023
Supreme Court Won’t Hear Skinny Label Case Foley & Lardner LLP
May
16
2023
Software as a Medical Device: Challenges Facing the Industry Foley & Lardner LLP
May
16
2023
Federal Circuit Considers Patentability of Overlapping Ranges Foley & Lardner LLP
May
16
2023
Public Nuisance Claims: Altria’s Vaping Trial Highlights Potential Expansion Foley & Lardner LLP
May
15
2023
10 Legal Challenges for the Cannabis Industry in 2023 ArentFox Schiff LLP
May
15
2023
U.S. Department of Transportation Allows Oral Fluid Drug Testing Jackson Lewis P.C.
May
15
2023
Does California Charter Law Breakers? Allen Matkins Leck Gamble Mallory & Natsis LLP
May
15
2023
Regulatory Nexus and TSCA Risk Management Rules – Never the Twain Shall Meet? Keller and Heckman LLP
May
15
2023
DEA Temporarily Extends COVID-19 Flexibilities for Controlled Substance Prescriptions via Telemedicine While Evaluating Permanent Rule Changes K&L Gates
May
15
2023
Hepatitis A Outbreak Linked to Frozen, Organic Strawberries Keller and Heckman LLP
May
15
2023
U.S. Supreme Court Upholds California’s Prevention of Cruelty to Farm Animals Act (Proposition 12) Keller and Heckman LLP
May
14
2023
NC Retail Permits Cancelled – But a Solution Is Available Ward and Smith, P.A.
May
14
2023
DEA Temporary Rule Extends Telemedicine Flexibilities Through November 2023 and Grants Additional One-Year Grace Period Polsinelli PC
May
13
2023
CMS-Certified Healthcare Facilities Left in the “Waiting Room” After Other COVID Vaccination Requirements End Dinsmore & Shohl LLP
May
13
2023
Up In Smoke: USPTO Leaves Cannabis-Related Trademark Application in Ashes Bradley Arant Boult Cummings LLP
May
12
2023
DEA Extends Telemedicine Flexibilities for Prescribing of Controlled Medications Foley & Lardner LLP
May
12
2023
DEA Extends Pandemic Telehealth Prescribing Flexibilities For Up To 18 Months Robinson & Cole LLP
May
12
2023
What is “Just Fruit”?: Ninth Circuit Affirms Dismissal of False Advertising Suit Against Kroger Hunton Andrews Kurth
May
11
2023
Move Over Cannabis, the Movement to Legalize Psychedelic Mushrooms Is Ready to Share the Spotlight Womble Bond Dickinson (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins